Riskpilot← Back to searchSign inGet full accessTELEMARK VAKSINASJONSSENTER AS
ASActiveOrg 883903412Byfogd Paus Gate 10B, 3717 SkienOther human health activities n.e.c. · NACE 8699Est. 20013 employees
Revenue 2024
NOK 4,5M
-6% vs 2023
EBITDA margin
5.9%
-20% vs 2023
Equity ratio
32.5%
Financial strength
Net profit 2024
NOK -389K
-249% vs 2023
| Revenue | NOK 4,5M | -6% |
| EBITDA | NOK 265K | -20% |
| Net profit | NOK -389K | -249% |
| Total assets | NOK 1,4M | -49% |
| Equity | NOK 455K | -60% |
| Employees | 3 | — |
Legal name
TELEMARK VAKSINASJONSSENTER AS
Org number
883903412
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
17. november 2001
Share capital
NOK 375 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Vaksinasjon av reisende og arbeidstakere. Kursvirksomhet - førstehjelp. Salg av helserelaterte forbruksartikler.
Address
Byfogd Paus Gate 10B, 3717 Skien
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 158 | 2 236 | 3 903 | 4 751 | 4 461 |
| Staff expenses | −908 | −690 | −1 032 | −1 199 | −1 288 |
| EBITDA | 81 | 453 | 627 | 331 | 265 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 81 | 453 | 627 | 331 | 265 |
| Net financials | 1 | 0 | 2 | 4 | −596 |
| Profit before tax | 81 | 454 | 629 | 335 | −331 |
| Tax | 18 | 100 | 138 | 74 | 58 |
| Net profit | 64 | 354 | 491 | 261 | −389 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 101 | 2 558 | 2 538 | 2 737 | 1 400 |
| Equity | 1 838 | 2 192 | 1 883 | 1 144 | 455 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 263 | 366 | 655 | 1 593 | 945 |
| Total debt | 263 | 366 | 655 | 1 593 | 945 |
EBITDA margin
5.9%
This company
15.8%
Market median
-63% vs market
20202024
Equity ratio
32.5%
This company
38.2%
Market median
+15% vs market
20202024
Return on equity
-85.6%
This company
18.4%
Market median
-565% vs market
20202024
Net profit margin
-8.7%
This company
8.1%
Market median
-207% vs market
20202024
Asset turnover
3.19×
This company
1.12×
Market median
+185% vs market
20202024
Debt / equity
2.08×
This company
0.62×
Market median
-235% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SA Deputy Member | Deputy Member | 2025 |
| Former (2) | ||
LM Chief Executive Officer | Chief Executive Officer | 2001 – 2025 |
PF Deputy Member | Deputy Member | 2011 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2011 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2024 | |
| Company | 20% | 20% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
TELEMARK VAKSINASJONSSENTER AS 
Fortunakvartalet AsBoard members of TELEMARK VAKSINASJONSSENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Siv Anne Kildahl Fjeld | Deputy Member | 0 companies |
| Liv Marianne Furuheim | Chief Executive Officer | 0 companies |
| Per Furuheim | Deputy Member | 0 companies |
| Bjørnar Fjeld | Chairman | 0 companies |